Ottobock
A medical technology company specializing in prosthetics and technical orthopaedics.
- Healthcare
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A Valuation: €3.2b 3.6x EV/Revenue 22.5x EV/EBITDA | Growth Equity non VC | |
* | €100m | Debt | |
* | €1.1b Valuation: €5.5b 3.7x EV/Revenue 19.6x EV/EBITDA | Secondary | |
| Total Funding | - | ||
| EUR | 2016 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | 8 % | 5 % | 13 % | 9 % | 15 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 16 % | 19 % | 19 % | 21 % | 20 % | 18 % | 19 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | - | 17 % | - | - | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Ottobock, founded in 1919 in Germany, is a global leader in orthopedic technology, specializing in prosthetics, orthotics, wheelchairs, and exoskeletons. Operating in nearly 60 countries, the company employs over 9,000 people and generates €1.5 billion annually. Ottobock's advanced products, including microprocessor-controlled prosthetics and ergonomic exoskeletons, enhance mobility and independence for individuals with disabilities. As a family-owned company, it is committed to innovation, quality, and social responsibility, demonstrated through its long-standing partnership with the Paralympic Games.
Keywords: Ottobock, orthopedic technology, prosthetics, orthotics, wheelchairs, exoskeletons, mobility solutions, disability support, Paralympic Games, innovation, Duderstadt, Germany.
Tech stack
Investments by Ottobock
Edit
